
    
      This study will investigate the clinical and laboratory variables that may be used to predict
      who among the solid organ transplant recipients will develop CMV disease after completing
      antiviral prophylaxis. This is a retrospective study of patients seen at the Mayo Clinic
      during the past five years.
    
  